Dr Killian Donovan
Colleges
Killian Donovan
BA BMBCh MRCP(UK) PGDip
DPhil Student and Clinical Research Fellow
Killian began his DPhil in October 2023 and is studying the genetic determinants of chronic kidney disease progression using data from large clinical trials, in a project funded by Kidney Research UK.
He aims to identify genetic variants associated with faster chronic kidney disease progression and validate these findings in diverse ancestry groups. This may lead to a better understanding of the biology of chronic kidney disease, which may lead to better treatments for patients.
Together with clinical work, he has conducted clinical and epidemiological research in critical care and nephrology, funded by an NIHR Academic Clinical Fellowship (2018-2021). Immediately prior to starting the DPhil, he was working as a registrar in nephrology and intensive care medicine.
Killian obtained his BA from Cambridge University and then completed his medical degree at Oxford, where he has lived and worked since graduating.
Recent publications
-
An application of the MR-Horse method to reduce selection bias in genome-wide association studies of disease progression
Journal article
Donovan KILLIAN. et al, (2025), European Journal of Human Genetics
-
Fibroblast Growth Factor-23 and Risk of Cardiovascular Diseases: A Mendelian Randomization Study.
Journal article
Donovan K. et al, (2023), Clin J Am Soc Nephrol, 18, 17 - 27
-
Intravenous iron to treat anaemia following critical care: a multicentre feasibility randomised trial.
Journal article
Shah A. et al, (2022), Br J Anaesth, 128, 272 - 282
-
Fibroblast Growth Factor-23 and Risk of Cardiovascular Diseases: a Mendelian Randomisation study
Preprint
Donovan K. et al, (2022)
-
Stored blood has compromised oxygen unloading kinetics that can be normalized with rejuvenation and predicted from corpuscular side-scatter.
Journal article
Donovan K. et al, (2022), Haematologica, 107, 298 - 302